Vegasor, you are way off IMO. Everybody said they
Post# of 148278
Everybody said they wanted to see our s/c data before moving on to approve us for m/m (after our Top Line m/m report came out)
FDA told Nader by email or ?? regarding our "request for feedback" on potential EUA for m/m, "let's wait for interim on s/c.
Well, interim analysis came in with great news/recommendations to continue and also, no issues, it's safe, efficacy supports continuation and further, we will take a look when at 293.
OK, so now give us our EUA for m/m, we had Clinical Significance on Primary Endpoint and Statistical Significance on Secondary Endpoint (vital NEW2). Nope, no EUA,
Then 2 days later, the FDA is fully exposed and corrupt, giving full FDA approval to remdesivir, clowns, a joke, an enormous scandal,
Our EUA for m/m could prevent massive suffering and prevent masses of folks from progressing to s/c.
So, I say let's go overseas pursuing m/m approvals first in Canada, the UK and the Philippines.